Clinical Trials Browser

Phase NA × Carcinoma, Non-Small-Cell Lung × tislelizumab × Clear all

NCT06607926 2024-09-23

Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung